
( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *exp*)
                          (NP-OB1 *T*)
                          (PP (NP (PP (NP (NPR ハーバード大学)
                                          (N 医学部))
                                      (P の))
                                  (N 図書館))
                              (P に))
                          (VB 飾っ)
                          (P て)
                          (VB2 ある))
                  (N 絵画))
          (AX です))
  (ID 1_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (PP (ADVP (ADV 初めて))
                              (P の))
                          (N 臓器移植))
                      (P の))
                  (N 様子))
              (P が))
          (NP-SBJ *が*)
          (VB 描か)
          (PASS れ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 2_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (NPR ジョー・ミュレー))
                      (P の))
                  (N 様子))
              (P が))
          (NP-SBJ *が*)
          (VB 伺え)
          (AX ます))
  (ID 3_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ そして)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-OB1 (N 後ろ))
                          (AX の))
                  (N 部屋))
              (P に)
              (P は))
          (PP (NP (IP-EMB (PP (NP (IP-REL (NP-SBJ *T*)
                                          (NP-PRD (PP (NP (NPR ハーバード))
                                                      (P の))
                                                  (N 泌尿器科科長))
                                          (AX で)
                                          (VB2 ある))
                                  (NPR ハートウェル・ハリソン))
                              (P が))
                          (NP-SBJ *が*)
                          (PP (NP (N 腎臓))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 摘出)
                          (VB0 し)
                          (P て)
                          (VB2 いる))
                  (N 様子))
              (P が))
          (NP-SBJ *が*)
          (VB 描か)
          (PASS れ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 4_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (ADVP (ADV 実に))
          (PP (NP (N 腎臓))
              (P こそ)
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 人間))
                              (P に))
                          (VB 移植)
                          (VB0 さ)
                          (PASS れ)
                          (AXD た))
                  (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 最初))
                          (AX の))
                  (N 臓器))
          (AX な)
          (FN の)
          (AX です))
  (ID 5_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO それ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (PP;* (NP (NUMCLP (NUM 1954)
                                    (CL 年)))
                        (P の))
                  (N こと))
          (AX でし)
          (AXD た))
  (ID 6_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PP (NP (NUMCLP (NUM 55)
                                                  (CL 年)))
                                      (P も))
                                  (N 前))
                          (AX の))
                  (N 話))
          (AX です))
  (ID 7_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO 我々))
              (P は))
          (NP-SBJ *)
          (PP-TMP (NP (IP-EMB (PP (NP (NUMCLP (WNUM 何十)
                                              (CL 年)))
                                  (P も))
                              (NP-SBJ *)
                              (VB 経っ)
                              (AXD た))
                      (N 今))
                  (P も))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADJN 同じ)
                          (AX *))
                  (N 難題))
              (P に))
          (VB 挑戦)
          (VB0 し)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 8_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (ADVP (ADV もちろん))
          (IP-ADV (PP (NP (PP;* (NP (Q たくさん))
                                (P の))
                          (N 医学的進歩))
                      (P が))
                  (NP-SBJ *が*)
                  (VB あり))
          (PP (NP (PP;* (NP (Q たくさん))
                        (P の))
                  (N 命))
              (P が))
          (NP-SBJ *が*)
          (VB 救わ)
          (PASS れ)
          (AX まし)
          (AXD た))
  (ID 9_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ しかし)
          (PP (NP (PRO 私たち))
              (P は))
          (NP-SBJ *)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADJN 重大)
                          (AX な))
                  (PP (NP (N 臓器))
                      (P の))
                  (N 不足))
              (P に))
          (VB 直面)
          (VB0 し)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 10_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (PP (NP (N 臓器移植))
                                      (P の))
                                  (N 順番))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 待つ))
                  (N 患者))
              (P は))
          (NP-SBJ *)
          (PP (NP (PRO ここ)
                  (NUMCLP (NUM 十)
                          (CL 年)))
              (P で))
          (PP (NP (NUMCLP (NUM ２)
                          (CL 倍)))
              (P に))
          (VB 増え)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 11_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (D その)
                  (N 一方))
              (P で))
          (PP (NP (PP (NP (N 臓器移植))
                      (P の))
                  (N 手術数))
              (P は))
          (NP-SBJ *)
          (NP;*SBJ* (Q ほとんど))
          (VB 増え)
          (P て)
          (VB2 い)
          (AX ませ)
          (NEG ん))
  (ID 12_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (IP-ADV (NP-PRD (IP-EMB (PP (NP (N 高齢化))
                                      (P が))
                                  (NP-SBJ *が*)
                                  (VB 関っ)
                                  (P て)
                                  (VB2 いる))
                          (N ため))
                  (AX で))
          (CONJ *)
          (PP-PRD (IP-ADV (PP (NP (N 寿命))
                              (P が))
                          (NP-SBJ *が*)
                          (VB 延び)
                          (P て)
                          (VB2 いる))
                  (P から))
          (AX です))
  (ID 13_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (N 医学))
                      (P の))
                  (N 進歩))
              (P によって))
          (PP (NP (PRO 私たち))
              (P は))
          (NP-SBJ *)
          (VB 長生き)
          (VB0 でき)
          (P て)
          (VB2 いる)
          (FN の)
          (AX です))
  (ID 14_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ しかし)
          (PP (IP-ADV (PP (NP (PRO 私たち))
                          (P が))
                      (NP-SBJ *が*)
                      (PP (NP (N 年))
                          (P を))
                      (NP-OB1 *を*)
                      (VB 重ねる))
              (P とともに))
          (SCON *)
          (PP (NP (PP (NP (PRO 私たち))
                      (P の))
                  (N 臓器))
              (P は))
          (NP-SBJ *)
          (VB 衰え)
          (P て)
          (VB2 ゆく)
          (FN の)
          (AX です))
  (ID 15_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (PRO 私たち))
                              (P に))
                          (VB 課せ)
                          (PASS られ)
                          (AXD た))
                  (N 難題))
          (AX です))
  (ID 16_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (CONJP (NP (N 臓器))
                         (CONJ だけではなく))
                  (NP (N 組織)))
              (P も))
          (NP-SBJ *)
          (VB 衰え)
          (P て)
          (VB2 行き)
          (AX ます))
  (ID 17_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (NP (CONJP (NP (PP (NP (N 膵臓))
                                 (P の))
                             (N 移植))
                         (P や))
                  (NP (PP (NP (IP-EMB (NP-SBJ *pro*)
                                      (PP (NP (N パーキンソン病))
                                          (P を))
                                      (NP-OB1 *を*)
                                      (VB 和らげる))
                              (N ため))
                          (P の))
                      (PP (NP (N 神経))
                          (P の))
                      (N 移植)))
              (P に))
          (VB 挑戦)
          (VB0 し)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 18_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これら))
              (P に)
              (P は))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADJN 重大)
                          (AX な))
                  (N 問題))
              (P が))
          (NP-SBJ *が*)
          (VB 伴い)
          (AX ます))
  (ID 19_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (PP (NP (IP-REL (NP-OB1 *T*)
                                      (NP-SBJ *exp*)
                                      (VB 驚く)
                                      (MD べき))
                              (N 統計データ))
                          (P が))
                      (NP-SBJ *が*)
                      (VB ある)
                      (FN の)
                      (AX です))
              (P が))
          (CONJ *)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PP (NP (NUMCLP (NUM 30)
                                                  (CL 秒)))
                                      (P に))
                                  (NUMCLP (NUM １人)))
                          (AX の))
                  (N 割合))
              (P で))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (IP-ADV (NP-SBJ *pro*)
                                  (IP-ADV (PP (NP (PP (NP (N 体))
                                                      (P の))
                                                  (Q 一部))
                                              (P を))
                                          (NP-OB1 *を*)
                                          (IP-SMC (VB 再生)
                                                  (VB0 さ))
                                          (VB せ)
                                          (P たり))
                                  (CONJ *)
                                  (PP (NP (N 移植))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB すれ)
                                  (P ば))
                          (CND *)
                          (VB 助かる))
                  (N 患者))
              (P が))
          (NP-SBJ *が*)
          (VB 亡くなっ)
          (P て)
          (VB2 いる)
          (FN の)
          (AX です))
  (ID 20_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-QUE (IP-SUB (CONJ では)
                  (PP (NP (PRO 私たち))
                      (P に))
                  (NP-SBJ *に*)
                  (PP (NP (WPRO 何))
                      (P が))
                  (NP-OB1 *が*)
                  (VB できる)
                  (FN の)
                  (AX でしょ)
                  (MD う))
          (P か)
          (PU ？))
  (ID 21_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (PP-TMP (NP (N 今晩))
                  (P は))
          (PP (NP (N 幹細胞))
              (P について))
          (VB お話)
          (VB0 し)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 22_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO それ))
              (P こそ))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-OB1 *T*)
                          (PP (NP (PRO 私たち))
                              (P が))
                          (NP-SBJ *が*)
                          (VB 取る)
                          (MD べき))
                  (N 手段))
          (AX な)
          (FN の)
          (AX です))
  (ID 23_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ しかし)
          (PP (IP-NML (NP-SBJ *speaker+pro*)
                      (PP (NP (N 幹細胞治療))
                          (P を))
                      (NP-OB1 *を*)
                      (VB 臨床応用)
                      (VB0 する))
              (P に)
              (P は))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADJI 長い))
                  (N 道のり))
              (P が))
          (NP-SBJ *が*)
          (VB あり)
          (AX ます))
  (ID 24_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-QUE (IP-SUB (NP-SBJ *hearer*)
                  (CP-THT (IP-SUB (NP-SBJ *pro*)
                                  (IP-ADV (NP-SBJ *speaker+pro*)
                                          (PP (NP (PP (NP (PRO 私たち))
                                                      (P の))
                                                  (N 体))
                                              (P を))
                                          (NP-OB1 *を*)
                                          (IP-SMC (VB 再生)
                                                  (VB0 さ))
                                          (VB せ)
                                          (VB2 られ)
                                          (P たら))
                                  (CND *)
                                  (ADJI 素晴らしい))
                          (P と))
                  (VB 思い)
                  (AX ませ)
                  (NEG ん))
          (P か)
          (PU ？))
  (ID 25_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-QUE (IP-SUB (NP-SBJ *hearer*)
                  (CP-THT (IP-SUB (NP-SBJ *pro*)
                                  (IP-ADV (NP-SBJ *speaker+pro*)
                                          (ADVP (ADV もし))
                                          (PP (NP (IP-EMB (IP-ADV (PP (NP (PP (NP (PP (NP (PRO 私たち)
                                                                                          (PRN (NP (PRO 自身))))
                                                                                      (P の))
                                                                                  (N 体))
                                                                              (P の))
                                                                          (N 力))
                                                                      (P を))
                                                                  (NP-OB1 *を*)
                                                                  (VB 活用)
                                                                  (VB0 し)
                                                                  (P て))
                                                          (CONJ *)
                                                          (NP-OB1 *pro*)
                                                          (IP-SMC (VB 回復)
                                                                  (VB0 さ))
                                                          (VB せる))
                                                  (N こと))
                                              (P が))
                                          (NP-OB1 *が*)
                                          (PP (NP (N 実際))
                                              (P に))
                                          (VB でき)
                                          (P たら))
                                  (CND *)
                                  (ADJI 素晴らしい))
                          (P と))
                  (VB 思い)
                  (AX ませ)
                  (NEG ん))
          (P か)
          (PU ？))
  (ID 26_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (IP-ADV (NP-PRD (IP-REL (NP-SBJ *T*)
                                  (PP (NP (N 日常))
                                      (P から))
                                  (VB かけ離れ)
                                  (AX た))
                          (N 概念))
                  (AX な)
                  (FN の)
                  (AX で)
                  (P は)
                  (NEG なく))
          (CONJ *)
          (ADVP (ADV 実は))
          (NP-ADV *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 地球上))
                              (P で))
                          (NP-TMP (N 日々))
                          (VB 起こっ)
                          (P て)
                          (VB2 いる))
                  (N こと))
          (AX な)
          (FN の)
          (AX です))
  (ID 27_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (PP (NP (N サンショウウオ))
                      (P の))
                  (N 写真))
          (AX です))
  (ID 28_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N サンショウウオ))
              (P は))
          (NP-SBJ *)
          (PP (NP (D この)
                  (N よう))
              (P に))
          (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *exp*)
                          (VB 驚く)
                          (MD べき))
                  (N 再生能力))
              (P を))
          (NP-OB1 *を*)
          (VB 持っ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 29_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *hearer*)
                          (PP (NP (N ビデオ))
                              (P で))
                          (VB ご覧)
                          (P に)
                          (VB2 なっ)
                          (P て)
                          (VB2 いる))
                  (N の))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (VB 損傷)
                          (VB0 し)
                          (AXD た))
                  (PP (NP (N サンショウウオ))
                      (P の))
                  (N 足))
          (AX です))
  (ID 30_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (NP-PRD (IP-EMB (NP-SBJ *pro*)
                          (PP (NP (N 実際))
                              (P に))
                          (PP (NP (IP-EMB (PP (NP (PP (NP (N サンショウウオ))
                                                      (P の))
                                                  (N 足))
                                              (P が))
                                          (NP-SBJ *が*)
                                          (PP (NP (PP;* (NP (NUMCLP (NUM 数)
                                                                    (CL 日)))
                                                        (P の))
                                                  (N うち))
                                              (P に))
                                          (VB 再生)
                                          (VB0 する))
                                  (N 様子))
                              (P を))
                          (NP-OB1 *を*)
                          (IP-ADV (NP-SBJ *pro*)
                                  (PP (NP (N 時間))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB 追っ)
                                  (P て))
                          (CONJ *)
                          (VB 撮影)
                          (VB0 し)
                          (AXD た))
                  (N 写真))
          (AX です))
  (ID 31_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-FINAL (IP-SUB (PP (NP (IP-EMB (PP (NP (N 瘢痕))
                                        (P が))
                                    (NP-SBJ *が*)
                                    (VB でき)
                                    (P て)
                                    (VB2 いる))
                            (N の))
                        (P が))
                    (NP-SBJ *が*)
                    (VB 見え)
                    (AX ます))
            (P ね))
  (ID 32_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (N 瘢痕))
                      (P の))
                  (N 部分))
              (P から))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADJN 新た)
                          (AX な))
                  (N 足))
              (P が))
          (NP-SBJ *が*)
          (VB 伸び)
          (P て)
          (VB2 き)
          (AX ます))
  (ID 33_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N サンショウウオ))
              (P に)
              (P は))
          (NP-SBJ *に*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (D この)
                                  (N よう))
                          (AX な))
                  (N 事))
              (P が))
          (NP-OB1 *が*)
          (VB 出来る)
          (FN の)
          (AX です))
  (ID 34_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ *hearer*)
                      (CP-THT (CP-QUE (IP-SUB (ADVP (WADV なぜ))
                                              (PP (NP (N 人間))
                                                  (P は))
                                              (NP-SBJ *)
                                              (PP (NP (N 再生機能))
                                                  (P が))
                                              (NP-SBJ2 *が*)
                                              (ADJI ない)
                                              (FN の))
                                      (P か))
                              (P と))
                      (VB 思う)
                      (MD でしょう))
              (P が))
          (CONJ *)
          (PP (NP (PRO 我々))
              (P も))
          (NP-SBJ *)
          (PP (NP (IP-EMB (NP-SBJ *pro*)
                          (VB 再生)
                          (VB0 する))
                  (N 力))
              (P を))
          (NP-OB1 *を*)
          (VB もっ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 35_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (IP-ADV (IP-ADV (PP (NP (PP;* (NP (Q 皆さん))
                                        (P の))
                                  (N 体))
                              (P に)
                              (P は))
                          (NP;*SBJ* (Q たくさん))
                          (PP (NP (N 臓器))
                              (P が))
                          (NP-SBJ *が*)
                          (VB あり))
                  (CONJ *)
                  (PP (NP (PP;* (NP (Q それぞれ))
                                (P の))
                          (N 臓器))
                      (P に)
                      (P は))
                  (PP (NP (IP-REL (NP-SBJ *T*)
                                  (PP (NP (IP-EMB (NP-SBJ *pro*)
                                                  (VB 傷つい)
                                                  (AXD た))
                                          (N とき))
                                      (P に))
                                  (VB 働き)
                                  (VB2 だす))
                          (N 細胞群))
                      (P が))
                  (NP-SBJ *が*)
                  (VB 備わっ)
                  (P て)
                  (VB2 おり))
          (CONJ *)
          (IP-ADV (NP-SBJ (N 休み))
                  (ADJI なく))
          (VB 働い)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 36_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (PP (NP (Q 皆さん))
                          (P が))
                      (NP-SBJ *が*)
                      (PP (NP (N 年))
                          (P を))
                      (NP-OB1 *を*)
                      (VB とる))
              (P につれて))
          (SCON *)
          (PP (NP (PP;* (NP (Q 皆さん))
                        (P の))
                  (N 骨))
              (P は))
          (NP-SBJ *)
          (PP (NP (NUMCLP (NUM 10)
                          (CL 年)))
              (P ごと)
              (P に))
          (VB 再生)
          (VB0 さ)
          (VB2 れ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 37_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP;* (NP (Q 皆さん))
                        (P の))
                  (N 皮膚))
              (P も))
          (NP-SBJ *)
          (PP (NP (NUMCLP (NUM 2)
                          (CL 週間)))
              (P ごと)
              (P に))
          (VB 再生)
          (VB0 さ)
          (VB2 れ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 38_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP;* (NP (Q 皆さん))
                        (P の))
                  (N 体))
              (P は))
          (NP-SBJ *)
          (PP (NP (N 常))
              (P に))
          (VB 再生)
          (VB0 さ)
          (VB2 れ)
          (VB2 続け)
          (P て)
          (VB2 いる)
          (FN の)
          (AX です))
  (ID 39_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-TMP (IP-EMB (PP (NP (N 体))
                              (P が))
                          (NP-SBJ *が*)
                          (VB 傷つい)
                          (AXD た))
                  (N とき))
          (PP (NP (PP (NP (D その)
                          (N 再生))
                      (P の))
                  (N 挑戦))
              (P が))
          (NP-SBJ *が*)
          (VB 始まる)
          (FN の)
          (AX です))
  (ID 40_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ *pro*)
                      (IP-ADV (PP (NP (N 怪我))
                                  (P を))
                              (NP-OB1 *を*)
                              (VB し)
                              (P たり))
                      (CONJ *)
                      (PP (NP (N 病気))
                          (P に))
                      (NP-OB1 *に*)
                      (VB なる))
              (P と))
          (CND *)
          (ADVP (ADV まず))
          (PP (NP (N 体))
              (P は))
          (NP-SBJ *)
          (PP (NP (IP-EMB (PP (NP (CONJP (NP (N 傷))
                                         (P や))
                                  (NP (N 病気)))
                              (P が))
                          (NP-SBJ *が*)
                          (PP (NP (PP (NP (N ほか))
                                      (P の))
                                  (N 部分))
                              (P に))
                          (VB 広がら)
                          (NEG ない))
                  (N よう))
              (P に))
          (NP-OB1 *pro*)
          (VB 封じ込め)
          (MD ようとし)
          (AX ます))
  (ID 41_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (NP-OB1 *pro*)
          (NP-ADV (IP-EMB (PP (NP (PP (NP (N 体))
                                      (P の))
                                  (PP (NP (N 他))
                                      (P の))
                                  (N 部分))
                              (P へ))
                          (PP (NP (N 感染))
                              (P が))
                          (NP-SBJ *が*)
                          (VB 広がら)
                          (NEG ない))
                  (N よう))
          (VB 封じ込め)
          (MD ようとし)
          (AX ます))
  (ID 42_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (IP-ADV (PP (NP (PRO それ))
                      (P は))
                  (NP-SBJ *)
                  (IP-ADV (NP-PRD (N 臓器))
                          (AX で)
                          (VB2 あれ))
                  (CONJ *)
                  (NP-PRD (N 皮膚))
                  (AX で)
                  (VB2 あれ))
          (CND *)
          (PP-TPC (NP (IP-REL (NP-SBJ *T*)
                              (NP-PRD (N 最初))
                              (AX の))
                      (N 反応))
                  (P は))
          (PP (IP-ADV (NP-SBJ *pro*)
                      (NP-OB1 *pro*)
                      (PP (NP (N 外部))
                          (P と))
                      (VB 遮断)
                      (VB0 する))
              (P ために))
          (SCON *)
          (PP (NP (N 瘢痕組織))
              (P が))
          (NP-SBJ *が*)
          (VB つくら)
          (PASS れ)
          (AX ます))
  (ID 43_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-QUE (IP-SUB (CONJ では)
                  (PP (NP (IP-EMB (NP-SBJ *speaker+pro*)
                                  (PP (NP (D この)
                                          (IP-REL (NP-SBJ *T*)
                                                  (PP (NP (N 傷))
                                                      (P を))
                                                  (NP-OB1 *を*)
                                                  (VB 封じ込め)
                                                  (MD ようとする))
                                          (N 力))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB 利用)
                                  (VB0 する))
                          (N 方法))
                      (P は))
                  (NP-SBJ *)
                  (VB ある)
                  (FN の)
                  (AX でしょ)
                  (MD う))
          (P か)
          (PU ？))
  (ID 44_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (IP-ADV (NP-SBJ *pro*)
                                  (ADVP (ADV 現に))
                                  (PP (NP (IP-REL (NP-SBJ *T*)
                                                  (ADJN 高性能)
                                                  (AX な))
                                          (N 生体材料))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB 用い)
                                  (P て))
                          (CONJ *)
                          (VB 実用化)
                          (VB0 さ)
                          (PASS れ)
                          (P て)
                          (VB2 いる))
                  (N の))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (D その)
                  (NUMCLP (NUM 一)
                          (CL つ)))
          (AX です))
  (ID 45_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+hearer*)
          (CP-QUE-OB1 (IP-SUB (NP-SBJ *pro*)
                              (ADVP (WADV どのように))
                              (VB 役立つ)
                              (FN の))
                      (P か))
          (VB 見)
          (P て)
          (VB2 み)
          (AX ましょ)
          (MD う))
  (ID 46_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 左))
                          (AX の))
                  (N 写真))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (VB 損傷)
                          (VB0 し)
                          (AXD た))
                  (N 尿道))
          (AX です))
  (ID 47_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 膀胱))
                              (P から))
                          (PP (NP (PP (NP (N 体))
                                      (P の))
                                  (N 外))
                              (P に))
                          (VB つながる))
                  (N 管))
          (AX です))
  (ID 48_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (NP (D この)
                  (N よう))
              (P に))
          (VB 傷つい)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 49_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (ADVP (ADV まず))
          (PP (NP (IP-EMB (PP (NP (D その)
                                  (IP-REL (NP-SBJ *T*)
                                          (ADJN 高性能)
                                          (AX な))
                                  (N 生体材料))
                              (P を))
                          (NP-OB1 *を*)
                          (PP (NP (PP (NP (N 橋)
                                          (PRN (-LRB- （)
                                               (NP (N ブリッジ))
                                               (-RRB- ）)))
                                      (P の))
                                  (N よう))
                              (P に))
                          (VB 利用)
                          (VB0 できる))
                  (N こと))
              (P を))
          (NP-OB1 *を*)
          (VB 発見)
          (VB0 し)
          (AX まし)
          (AXD た))
  (ID 50_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (IP-ADV (PP (NP (N ブリッジ))
                              (P を))
                          (NP-OB1 *を*)
                          (VB つくり))
                  (PP (NP (IP-EMB (NP-OB1 *pro*)
                                  (PP (NP (PP (NP (N 外部))
                                              (P の))
                                          (N 環境))
                                      (P から))
                                  (VB 封じ込める))
                          (N こと))
                      (P が))
                  (NP-OB1 *が*)
                  (VB できれ)
                  (P ば))
          (CND *)
          (PP (NP (IP-EMB (PP (NP (IP-REL (NP-OB1 *T*)
                                          (NP-SBJ *speaker+pro*)
                                          (IP-SMC (PP (NP (N 体内))
                                                      (P で))
                                                  (VB 再生)
                                                  (VB0 さ))
                                          (VB せ)
                                          (AXD た))
                                  (N 細胞))
                              (P に))
                          (NP-OB1 *に*)
                          (IP-ADV (IP-SMC (PP (NP (N ブリッジ))
                                              (P を))
                                          (NP-OB1 *を*)
                                          (VB 渡ら))
                                  (VB せ)
                                  (P て))
                          (CONJ *)
                          (IP-SMC (PP (NP (N 尿道))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB たどら))
                          (VB せる))
                  (N こと))
              (P が))
          (NP-OB1 *が*)
          (VB できる)
          (FN の)
          (AX です))
  (ID 51_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (D その)
                  (N 様子))
          (AX です))
  (ID 52_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (IP-REL (NP-OB1 *T*)
                          (PP (NP (PRO 私たち))
                              (P が))
                          (NP-SBJ *が*)
                          (PP (NP (N 実際))
                              (P に))
                          (PP (NP (PP (NP (D この)
                                          (N 患者))
                                      (P の))
                                  (N 治療))
                              (P に))
                          (VB 用い)
                          (AXD た))
                  (IP-REL (NP-SBJ *T*)
                          (ADJN 高性能)
                          (AX の))
                  (N 生体材料))
          (AX です))
  (ID 53_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 左))
                              (P に))
                          (VB 見える))
                  (N の))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (VB 損傷)
                          (VB0 し)
                          (AXD た))
                  (N 尿道))
          (AX です))
  (ID 54_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *speaker*)
                          (PP (NP (N 中央))
                              (P に))
                          (VB 示し)
                          (P て)
                          (VB2 いる))
                  (N 生体材料))
              (P を))
          (NP-OB1 *を*)
          (VB 用い)
          (AX まし)
          (AXD た))
  (ID 55_ted_talk_9;AnthonyAtala_2009P;JP))

( (FRAG (CONJ そして)
        (NP-TMP (NUMCLP (NUM 6)
                        (CL ヶ月))
                (N 後))
        (PU ・・・))
  (ID 56_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 右))
                              (P に))
                          (VB 見える))
                  (N の))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (VB 再生)
                          (VB0 さ)
                          (PASS れ)
                          (AXD た))
                  (N 尿道))
          (AX です))
  (ID 57_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ *pro*)
                      (PP (NP (IP-REL (NP-SBJ *T*)
                                      (ADJI 短い))
                              (N 間隔))
                          (P に))
                      (VB 限っ)
                      (P て)
                      (P だけ)
                      (AX です))
              (P が))
          (CONJ *)
          (PP (NP (PP (NP (PRO 私たち))
                      (P の))
                  (N 体))
              (P は))
          (NP-SBJ *)
          (VB 再生)
          (VB0 できる)
          (FN の)
          (AX です))
  (ID 58_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CP-THT-SBJ (IP-SUB (NP-SBJ *pro*)
                              (PP (NP (NUMCLP (NUM １)
                                              (CL cm)))
                                  (P まで)
                                  (P しか))
                              (VB 再生)
                              (VB0 でき)
                              (NEG ない))
                      (P と))
          (VB 言わ)
          (PASS れ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 59_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-OB1 *pro*)
          (PP (NP (N 高性能生体材料))
              (P で)
              (P も))
          (NP-SBJ *で*)
          (PP;*OB1* (NP (NUMCLP (NUM １)
                                (CL cm)))
                    (P まで)
                    (P しか))
          (VB カバー)
          (VB0 でき)
          (NEG ない)
          (FN の)
          (AX です))
  (ID 60_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO 私たち))
              (P は))
          (NP-SBJ *)
          (PP (NP (IP-EMB (NP-OB1 *pro*)
                          (IP-ADV (NP-SBJ *exp*)
                                  (NP-PRD (IP-REL (NP-SBJ *T*)
                                                  (ADJI 短い))
                                          (N 間隔))
                                  (AX で)
                                  (VB2 あれ)
                                  (P ば))
                          (CND *)
                          (VB 再生)
                          (VB0 する))
                  (N こと))
              (P が))
          (NP-OB1 *が*)
          (VB できる)
          (FN の)
          (AX です))
  (ID 61_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-QUE (IP-SUB (NP-SBJ *speaker+pro*)
                  (NP-ADV (IP-EMB (PP (NP (IP-REL (NP-SBJ *T*)
                                                  (ADVP (ADV より))
                                                  (ADJN 大きな)
                                                  (AX *))
                                          (N 臓器))
                                      (P が))
                                  (NP-SBJ *が*)
                                  (VB 損傷)
                                  (VB0 し)
                                  (AXD た))
                          (N 場合))
                  (ADVP (WADV どう))
                  (VB すれ)
                  (MD ば良い)
                  (FN の)
                  (AX でしょ)
                  (MD う))
          (P か))
  (ID 62_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-QUE (IP-SUB (NP-SBJ *speaker+pro*)
                  (NP-TMP (IP-EMB (PP (NP (PP (NP (N 組織))
                                              (P の))
                                          (N 損傷))
                                      (P が))
                                  (NP-SBJ *が*)
                                  (NP-PRD (NUMCLP (NUM 1)
                                                  (CL cm))
                                          (N 以上))
                                  (AX の))
                          (N 場合))
                  (ADVP (WADV どう))
                  (VB すれ)
                  (MD ば良い)
                  (FN の)
                  (AX でしょ)
                  (MD う))
          (P か)
          (PU ？))
  (ID 63_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (D この)
                                  (N よう))
                          (AX な))
                  (N 時))
              (P に)
              (P は))
          (NP-PRD (PP (NP (N 細胞))
                      (P の))
                  (N 出番))
          (AX です))
  (ID 64_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *speaker+pro*)
                          (PP (NP (PRO ここ))
                              (P で))
                          (VB 取る))
                  (N 戦略))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (NP-PRD (IP-REL (NP-SBJ *T*)
                                          (NP-PRD (N 次))
                                          (AX の))
                                  (N よう))
                          (AX な))
                  (N もの))
          (AX です))
  (ID 65_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N 患者))
              (P が))
          (NP-SBJ *が*)
          (IP-ADV (PP (NP (N 臓器))
                      (P に))
                  (PP (NP (N 問題))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 抱え)
                  (P て))
          (CONJ *)
          (VB 来院)
          (VB0 し)
          (AX ます))
  (ID 66_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (PP (NP (D その)
                          (N 患者))
                      (P の))
                  (N 臓器))
              (P から))
          (PP (NP (Q 一部))
              (P を))
          (NP-OB1 *を*)
          (VB 採取)
          (VB0 し)
          (AX ます))
  (ID 67_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PP (NP (N 切手))
                                      (P の))
                                  (Q 半分)
                                  (N 以下))
                          (AX の))
                  (N 大きさ))
          (AX です))
  (ID 68_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そして)
          (IP-ADV (IP-ADV (PP (NP (N 組織))
                              (P を))
                          (NP-OB1 *を*)
                          (ADVP (ADV 細かく))
                          (VB 切っ)
                          (P て))
                  (CONJ *)
                  (PP (NP (IP-REL (NP-SBJ *T*)
                                  (ADJN 基本的)
                                  (AX な))
                          (N 成分))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 観察)
                  (VB0 し))
          (CONJ *)
          (IP-ADV (PP (NP (PP (NP (N 患者))
                              (P の))
                          (N 細胞))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 取り出し)
                  (P て))
          (CONJ *)
          (NP-OB1 *pro*)
          (IP-SMC (PP (NP (PP (NP (N 患者))
                              (P の))
                          (N 体外))
                      (P で))
                  (VB 培養)
                  (VB0 さ))
          (VB せ)
          (AX ます))
  (ID 69_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そして)
          (PP (NP (PRO ここ))
              (P で))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (PP (NP (N 臓器))
                                      (P の))
                                  (N 骨組み))
                              (P と))
                          (NP-OB1 *と*)
                          (VB なる))
                  (N 物質))
              (P を))
          (NP-OB1 *を*)
          (VB 用いる)
          (FN の)
          (AX です))
  (ID 70_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ *pro*)
                      (PP (NP (N 裸眼))
                          (P で)
                          (P は))
                      (IP-SMC (NP-PRD (PP (NP (PP (NP (N 洋服))
                                                  (P の))
                                              (N 切れ端))
                                          (P の))
                                      (N よう))
                              (AX に))
                      (VB 見え)
                      (AX ます))
              (P が))
          (CONJ *)
          (ADVP (ADV 実は))
          (PP (NP (D この)
                  (N 物質))
              (P は))
          (NP-SBJ *)
          (IP-ADV (ADVP (ADV きわめて))
                  (ADJN 複雑)
                  (AX で))
          (CONJ *)
          (PP (IP-ADV (PP (NP (N 体内))
                          (P に))
                      (VB 入る))
              (P と))
          (CND *)
          (VB 分解)
          (VB0 さ)
          (PASS れ)
          (P て)
          (VB2 しまい)
          (AX ます))
  (ID 71_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (NP (NUMCLP (NUM 数)
                          (CL カ月))
                  (N 後))
              (P に)
              (P は))
          (VB 分解)
          (VB0 さ)
          (PASS れ)
          (P て)
          (VB2 しまい)
          (AX ます))
  (ID 72_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (ADVP (ADV つまり))
          (PP-ADV (NP (IP-EMB (PP (NP (N 細胞))
                                  (P を))
                              (NP-OB1 *を*)
                              (IP-SMC (PP (NP (IP-REL (NP-SBJ *T*)
                                                      (ADJN 適切)
                                                      (AX な))
                                              (N 場所))
                                          (P に))
                                      (VB 行き)
                                      (VB2 渡ら))
                              (VB せる))
                      (N ため))
                  (P のみ))
          (VB 働く)
          (FN の)
          (AX です))
  (ID 73_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (N 体内))
                      (P に))
                  (PP (NP (N 細胞))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 運ん)
                  (P で))
          (CONJ *)
          (PP (NP (IP-EMB (PP (NP (IP-REL (NP-SBJ *T*)
                                          (ADJI 新しい))
                                  (N 組織))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 再生)
                          (VB0 できる))
                  (N よう))
              (P に))
          (VB し)
          (AX ます))
  (ID 74_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ そして)
          (PP (IP-ADV (PP (NP (N 組織))
                          (P が))
                      (NP-SBJ *が*)
                      (VB 再生)
                      (VB0 さ)
                      (PASS れる))
              (P と))
          (CND *)
          (PP (NP (N 骨組み))
              (P は))
          (NP-SBJ *)
          (VB 消え)
          (P て)
          (VB2 しまい)
          (AX ます))
  (ID 75_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *speaker+pro*)
                          (PP (NP (N 筋肉))
                              (P に))
                          (VB 施し)
                          (AXD た))
                  (N 方法))
              (P を))
          (NP-OB1 *を*)
          (VB お見せ)
          (VB0 し)
          (AX ます))
  (ID 76_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (PP (NP (PP (NP (CONJP (NP (PP (NP (N 筋組織))
                                         (P の))
                                     (Q 一部))
                                 (P と))
                          (NP (D その)
                              (N 構造)))
                      (P の))
                  (N つくり方))
              (P を))
          (NP-OB1 *を*)
          (VB 示し)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 77_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (IP-EMB (PP (NP (N 細胞))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (IP-ADV (VB 取り出し))
                                  (CONJ *)
                                  (VB 増やし)
                                  (AXD た))
                          (N 後))
                      (P に))
                  (PP (NP (N 細胞))
                      (P を))
                  (NP-OB1 *を*)
                  (PP (NP (N 骨組み))
                      (P に))
                  (VB 乗せ))
          (PP (NP (D その)
                  (N 骨組み))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (PP (NP (N 患者))
                      (P の))
                  (N 体))
              (P に))
          (VB 戻し)
          (AX ます))
  (ID 78_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ しかし)
          (PP (NP (IP-EMB (PP (NP (D その)
                                  (N 骨組み))
                              (P を))
                          (NP-OB1 *を*)
                          (PP (NP (PP (NP (N 患者))
                                      (P の))
                                  (N 体))
                              (P に))
                          (VB 戻す))
                  (N 前))
              (P に))
          (PP (NP (PP (NP (N できたて))
                      (P の))
                  (N 筋肉))
              (P に))
          (NP-OB1 *に*)
          (IP-SMC (PP (NP (N 運動))
                      (P を))
                  (NP-OB1 *を*)
                  (VB さ))
          (VB せる)
          (FN の)
          (AX です))
  (ID 79_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (NP-OB1 *pro*)
          (PP (NP (IP-EMB (PP (NP (N 筋組織))
                              (P が))
                          (NP-SBJ *が*)
                          (PP (NP (PP (NP (N 患者))
                                      (P の))
                                  (N 体内))
                              (P で))
                          (PP (NP (PP (NP (N 本来))
                                      (P の))
                                  (N 動き))
                              (P が))
                          (NP-OB1 *が*)
                          (VB できる))
                  (N よう))
              (P に))
          (IP-SMC (VB 運動)
                  (VB0 さ))
          (VB せ)
          (P て)
          (VB2 おく)
          (FN の)
          (AX です))
  (ID 80_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (D その)
                  (N 運動))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (PRO これ))
          (AX です))
  (ID 81_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (NP-OB1 *hearer*)
          (IP-SMC (PP (NP (IP-EMB (PP (NP (N 筋肉バイオリアクター))
                                      (P が))
                                  (NP-SBJ *が*)
                                  (PP (NP (N 筋肉))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (IP-SMC (PP (NP (N 前後))
                                              (P に))
                                          (VB 運動)
                                          (VB0 さ))
                                  (VB せ)
                                  (P て)
                                  (VB2 いる))
                          (N 様子))
                      (P を))
                  (NP-OB1 *を*)
                  (VB ご覧))
          (VB いただい)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 82_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (D この)
                  (IP-REL (NP-SBJ *T*)
                          (ADJN 平ら)
                          (AX な))
                  (N 組織))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (N 筋肉))
          (AX です))
  (ID 83_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-QUE (IP-SUB (NP-SBJ *pro*)
                  (CONJ それでは)
                  (PP (NP (IP-REL (NP-SBJ *T*)
                                  (NP-PRD (N 他))
                                  (AX の))
                          (N 組織))
                      (P で)
                      (P は))
                  (ADVP (WADV どう))
                  (AX でしょ)
                  (MD う))
          (P か)
          (PU ？))
  (ID 84_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 再生医療))
                              (P によって))
                          (NP-LGS *によって*)
                          (VB つくら)
                          (PASS れ)
                          (AXD た))
                  (N 人工血管))
          (AX です))
  (ID 85_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (IP-ADV (PP (NP (IP-EMB (NP-SBJ *speaker+pro*)
                                      (PP (NP (N 尿道))
                                          (P を))
                                      (NP-OB1 *を*)
                                      (VB つくる))
                              (N 工程))
                          (P と))
                      (VB 似)
                      (P て)
                      (VB2 い)
                      (AX ます))
              (P が))
          (CONJ *)
          (NP-ADV (ADV もう)
                  (Q 少し))
          (ADJN 複雑)
          (AX です))
  (ID 86_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (ADVP (ADV まず))
          (PP (NP (N 骨組み))
              (P を))
          (NP-OB1 *を*)
          (VB 準備)
          (VB0 し)
          (AX ます))
  (ID 87_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N 骨組み))
              (P は))
          (NP-SBJ *)
          (ADVP (ADV まるで))
          (NP-PRD (PP (NP (PP;* (NP (NUMCLP (NUM 一)
                                            (CL 枚)))
                                (P の))
                          (N 紙))
                      (P の))
                  (N よう))
          (AX です))
  (ID 88_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (PRO それ))
                      (P を))
                  (NP-OB1 *を*)
                  (PP (NP (N 筒状))
                      (P に))
                  (VB し)
                  (P て))
          (CONJ *)
          (PP (NP (N 血管))
              (P も))
          (NP-OB1 *)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADJN 同じ)
                          (AX *))
                  (N 方法))
              (P で))
          (VB つくり)
          (AX ます))
  (ID 89_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N 血管))
              (P は))
          (NP-SBJ *)
          (PP (NP (PP;* (NP (NUMCLP (NUM ２)
                                    (CL 種類)))
                        (P の))
                  (N 細胞))
              (P で))
          (VB 構成)
          (VB0 さ)
          (PASS れ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 90_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (PP (NP (N 筋肉))
                              (P の))
                          (N 細胞))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 取り出し))
          (PP (NP (IP-EMB (PP (NP (IP-REL (NP-SBJ *T*)
                                          (PP (NP (PP (NP (N 年輪))
                                                      (P の))
                                                  (N よう))
                                              (P に))
                                          (VB 重なる))
                                  (N ケーキ))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 焼く))
                  (N よう))
              (P に))
          (PP (NP (PP (NP (N 筒))
                      (P の))
                  (N 外側))
              (P に))
          (PP (NP (N 筋細胞))
              (P を))
          (NP-OB1 *を*)
          (VB 貼りつけ)
          (P て)
          (VB2 いき)
          (AX ます))
  (ID 91_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (N 内側))
              (P に)
              (P は))
          (PP (NP (N 血管内皮細胞))
              (P を))
          (NP-OB1 *を*)
          (VB 配置)
          (VB0 し)
          (AX ます))
  (ID 92_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (IP-REL (NP-OB2 *T*)
                          (PP (NP (N 細胞))
                              (P が))
                          (NP-SBJ *が*)
                          (VB 植え付け)
                          (PASS られ)
                          (AXD た))
                  (N 骨組み))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PP (NP (N オーブン))
                                      (P の))
                                  (N よう))
                          (AX な))
                  (N 装置))
              (P に))
          (VB 入れ)
          (AX ます))
  (ID 93_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (NP-OB1 *pro*)
          (IP-ADV (PP (NP (PP (NP (N 人間))
                              (P の))
                          (N 体内環境))
                      (P と))
                  (ADJN 同じ)
                  (AX で))
          (PP (NP (NML (N 摂氏)
                       (NUMCLP (NUM 37)
                               (CL 度)))
                  (NML (N 酸素)
                       (NUMCLP (NUM 95)
                               (CL ％))))
              (P に))
          (NP-OB2 *に*)
          (VB し)
          (P て)
          (VB2 あり)
          (AX ます))
  (ID 94_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (PP (NP (IP-REL (NP-SBJ *T*)
                                  (NP-PRD (N 先ほど))
                                  (AX の))
                          (N ビデオ))
                      (P の))
                  (N よう))
              (P に))
          (PP (NP (N 血管))
              (P を))
          (NP-OB1 *を*)
          (VB 動かし)
          (AX ます))
  (ID 95_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 右))
                              (P に))
                          (VB みえる))
                  (N の))
              (P は))
          (NP-SBJ *)
          (NP-PRD (N 人工頸動脈))
          (AX です))
  (ID 96_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N 頸動脈))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 首))
                              (P から))
                          (PP (NP (N 脳))
                              (P に))
                          (VB つながる))
                  (N 動脈))
          (AX です))
  (ID 97_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (D この)
                  (N レントゲン写真))
              (P で)
              (P は))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADVP (ADV きちんと))
                          (VB 機能)
                          (VB0 し)
                          (P て)
                          (VB2 いる))
                  (N 血管))
              (P が))
          (NP-SBJ *が*)
          (VB 見え)
          (AX ます))
  (ID 98_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (CONJP (NP (N 血管))
                         (P や))
                  (NP (N 尿道))
                  (P など))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (ADVP (ADV もっと))
                          (ADJN 複雑)
                          (AX な))
                  (N 組織))
          (AX です))
  (ID 99_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (CONJ なぜなら)
          (PP-PRD (IP-ADV (NP-SBJ *speaker+pro*)
                          (PP (NP (IP-EMB (PP (NP (PP;* (NP (NUMCLP (NUM 2)
                                                                    (CL 種)))
                                                        (P の))
                                                  (IP-REL (NP-SBJ *T*)
                                                          (VB 異なる))
                                                  (N 細胞))
                                              (P を))
                                          (NP-OB1 *を*)
                                          (VB 導入)
                                          (VB0 する))
                                  (N こと))
                              (P に))
                          (NP-OB1 *に*)
                          (VB なる))
                  (P から))
          (AX です))
  (ID 100_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ しかし)
          (PP (NP (N 実際))
              (P に))
          (PP (NP (PRO これら))
              (P は))
          (NP-SBJ *)
          (PP (NP (PP (NP (N 導管))
                      (P として)
                      (P の))
                  (N 役割))
              (P を))
          (NP-OB1 *を*)
          (VB 果たし)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 101_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (NP (IP-EMB (PP (NP (CONJP (NP (N 液体))
                                         (P か))
                                  (NP (N 空気)))
                              (P が))
                          (NP-SBJ *が*)
                          (PP (NP (IP-REL (NP-SBJ *T*)
                                          (NP-PRD (N 一定))
                                          (AX の))
                                  (N 状態))
                              (P で))
                          (VB 流れる))
                  (N よう))
              (P に))
          (NP-OB1 *に*)
          (VB なっ)
          (P て)
          (VB2 いる)
          (FN の)
          (AX です))
  (ID 102_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 管状))
                          (AX の))
                  (N 組織))
              (P は))
          (NP-SBJ *)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 空洞))
                          (AX の))
                  (N 臓器))
              (P ほど))
          (ADJN 複雑)
          (AX で)
          (P は)
          (VB2 あり)
          (AX ませ)
          (NEG ん))
  (ID 103_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP-PRD (IP-ADV (PP (NP (IP-REL (NP-SBJ *T*)
                                          (NP-PRD (N 空洞))
                                          (AX の))
                                  (N 臓器))
                              (P は))
                          (NP-SBJ *)
                          (IP-ADV (PP (NP (N 状況))
                                      (P に))
                                  (VB 応じ)
                                  (P て))
                          (CONJ *)
                          (VB 機能)
                          (VB0 する))
                  (P から))
          (AX です))
  (ID 104_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N 膀胱))
              (P も))
          (NP-SBJ *)
          (NP-PRD (PP (NP (IP-REL (NP-SBJ *T*)
                                  (NP-PRD (D その)
                                          (N よう))
                                  (AX な))
                          (N 臓器))
                      (P の))
                  (NUMCLP (NUM ひと)
                          (CL つ)))
          (AX です))
  (ID 105_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (NP-OB1 *pro*)
          (ADVP (ADJN 同様)
                (AX に))
          (IP-ADV (IP-ADV (PP (NP (N 膀胱))
                              (P から))
                          (PP (NP (IP-REL (NP-SBJ *T*)
                                          (NP-PRD (PP (NP (N 切手))
                                                      (P の))
                                                  (Q 半分)
                                                  (N 以下))
                                          (AX の))
                                  (N 大きさ))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 切り取り))
                  (CONJ *)
                  (PP (NP (D その)
                          (N 組織))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 分け)
                  (P て))
          (CONJ *)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (CONJP (NP (N 筋肉))
                                         (P と))
                                  (NP (N 膀胱)))
                              (P に))
                          (VB 特化)
                          (VB0 し)
                          (AX た))
                  (PP;* (NP (NUMCLP (NUM 二)
                                    (CL つ)))
                        (P の))
                  (N 細胞成分))
              (P に))
          (VB 分類)
          (VB0 し)
          (AX ます))
  (ID 106_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (N 体外))
              (P で))
          (PP (NP (N 細胞))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (Q 大量))
              (P に))
          (VB 増やし)
          (AX ます))
  (ID 107_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *speaker+pro*)
                          (PP (NP (N 臓器))
                              (P から))
                          (VB 取り出し)
                          (AXD た))
                  (N 細胞))
              (P は))
          (NP-OB1 *)
          (PP (NP (NUMCLP (NUM 約４)
                          (CL 週間)))
              (P で))
          (VB 培養)
          (VB0 でき)
          (AX ます))
  (ID 108_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そして)
          (PP (NP (N 骨組み))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PP (NP (N 膀胱))
                                      (P の))
                                  (N よう))
                          (AX な))
                  (N 形))
              (P に))
          (VB 整え)
          (AX ます))
  (ID 109_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (PP (NP (N 膀胱))
                      (P の))
                  (N 内面))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 内側用))
                          (AX の))
                  (N 細胞))
              (P で))
          (VB 覆い)
          (AX ます))
  (ID 110_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そして)
          (PP (NP (N 外側))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (PP (NP (N 筋肉))
                      (P の))
                  (N 細胞))
              (P で))
          (VB 覆い)
          (AX ます))
  (ID 111_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (NP-OB1 *pro*)
          (CONJ そして)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PP (NP (N オーブン))
                                      (P の))
                                  (N よう))
                          (AX な))
                  (N 装置))
              (P へ))
          (VB 戻し)
          (AX ます))
  (ID 112_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (PP (IP-ADV (PP (NP (PP (NP (N 組織))
                                          (P の))
                                      (Q 一部))
                                  (P を))
                              (NP-OB1 *を*)
                              (VB 採取)
                              (VB0 し)
                              (P て))
                      (P から))
                  (NUMCLP (NUM ６～８)
                          (CL 週間後)))
              (P に))
          (PP (NP (IP-EMB (PP (NP (N 臓器))
                              (P を))
                          (NP-OB1 *を*)
                          (PP (NP (PP (NP (N 患者))
                                      (P の))
                                  (N 体))
                              (P に))
                          (VB 戻す))
                  (N 事))
              (P が))
          (NP-OB1 *が*)
          (VB でき)
          (AX ます))
  (ID 113_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 実際))
                              (P に))
                          (PP (NP (N 骨組み))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 表し)
                          (AXD た))
                  (N もの))
          (AX です))
  (ID 114_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *exp*)
          (PP (NP (D この)
                  (N 物質))
              (P は))
          (NP-OB1 *)
          (PP (NP (N 細胞))
              (P で))
          (VB 覆っ)
          (P て)
          (VB2 あり)
          (AX ます))
  (ID 115_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP-TMP (NP (IP-EMB (PP (NP (N 臨床実験))
                                  (P を))
                              (NP-OB1 *を*)
                              (PP (NP (N 最初))
                                  (P に))
                              (VB 行っ)
                              (AXD た))
                      (N 時))
                  (P は))
          (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *speaker+pro*)
                          (PP (NP (QN 各患者))
                              (P に))
                          (VB 合わせ)
                          (AXD た))
                  (N 骨組み))
              (P を))
          (NP-OB1 *を*)
          (VB 作り)
          (AX まし)
          (AXD た))
  (ID 116_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (PP (NP (N 手術))
                              (P の))
                          (NUMCLP (NUM ６～８)
                                  (CL 週間))
                          (N 前))
                      (P に))
                  (PP (NP (N 患者))
                      (P に))
                  (NP-OB1 *に*)
                  (IP-SMC (VB 来)
                          (P て))
                  (VB もらい))
          (NP-TMP (PP (NP (N レントゲン撮影))
                      (P の))
                  (N 後))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (PP (NP (PP (NP (N 患者))
                                              (P の))
                                          (N 骨盤腔))
                                      (P の))
                                  (N 大きさ))
                              (P に))
                          (VB あっ)
                          (AXD た))
                  (N 骨組み))
              (P を))
          (NP-OB1 *を*)
          (ADVP (ADJN 特別)
                (AX に))
          (VB つくり)
          (AX まし)
          (AXD た))
  (ID 117_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そして)
          (PP (NP (PP (NP (N 臨床試験))
                      (P の))
                  (NUMCLP (NUM 第２)
                          (CL 期)))
              (P に)
              (P は))
          (PP (NP (NML (CONJP (NP (N 小)))
                       (CONJP (NP (N 中)))
                       (CONJP (NP (N 大)))
                       (NP (N 特大)))
                  (N サイズ))
              (P で))
          (PP (NP (N 骨組み))
              (P を))
          (NP-OB1 *を*)
          (VB つくり)
          (AX まし)
          (AXD た))
  (ID 118_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (NP-PRD (N 本当))
          (AX です))
  (ID 119_ted_talk_9;AnthonyAtala_2009P;JP))

( (CP-QUE (IP-SUB (PP-TPC (NP (Q 皆さん))
                          (P は))
                  (PP (NP (N 特大))
                      (P が))
                  (NP-SBJ *が*)
                  (ADJI いい)
                  (FN ん)
                  (AX でしょ)
                  (MD う))
          (PU ？))
  (ID 120_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N 膀胱))
              (P は))
          (NP-SBJ *)
          (ADVP (ADJN 明らか)
                (AX に))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 他))
                          (AX の))
                  (N 組織))
              (P よりも))
          (ADVP (ADV 少々))
          (ADJN 複雑)
          (AX な)
          (FN の)
          (AX です))
  (ID 121_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADVP (ADV さらに))
                          (ADJN 複雑)
                          (AX な))
                  (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 空洞))
                          (AX の))
                  (N 臓器))
              (P も))
          (NP-SBJ *)
          (VB あり)
          (AX ます))
  (ID 122_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-OB1 *T*)
                          (PP (NP (PRO 私たち))
                              (P が))
                          (NP-SBJ *が*)
                          (PP (NP (N 再生医療))
                              (P で))
                          (VB つくっ)
                          (AXD た))
                  (N 人工心臓弁))
          (AX です))
  (ID 123_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (N 心臓弁))
                      (P の))
                  (N 作り方))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (ADJN 同様)
                          (AX の))
                  (N 方法))
          (AX です))
  (ID 124_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (N 骨組み))
              (P に))
          (PP (NP (N 細胞))
              (P を))
          (NP-OB1 *を*)
          (VB のせ)
          (AX ます))
  (ID 125_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-ADV (PP (NP (N ご覧))
                      (P の))
                  (N とおり))
          (PP (NP (N 弁))
              (P が))
          (NP-SBJ *が*)
          (IP-ADV (VB 開い)
                  (P たり))
          (CONJ *)
          (VB 閉じ)
          (P たり)
          (VB2 し)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 126_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (IP-REL (NP-SBJ *T*)
                                  (ADJN 同じ)
                                  (AX *))
                          (N 方法))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 用い)
                  (P て))
          (CONJ *)
          (PP (NP (PP (NP (N 移植))
                      (P の))
                  (N 前))
              (P に))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PRO これら))
                          (AX の))
                  (N 臓器))
              (P に))
          (NP-OB1 *に*)
          (IP-SMC (PP (NP (N 運動))
                      (P を))
                  (NP-OB1 *を*)
                  (VB さ))
          (VB せ)
          (AX ます))
  (ID 127_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ そして)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (ADVP (ADV 最も))
                          (ADJN 複雑)
                          (AX な))
                  (N の))
              (P は))
          (NP-SBJ *)
          (NP-PRD (N 固形臓器))
          (AX です))
  (ID 128_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-EMB (PP (NP (N 固形臓器))
                              (P が))
                          (NP-SBJ *が*)
                          (ADVP (ADV より))
                          (ADJN 複雑)
                          (AX な))
                  (N の))
              (P は))
          (NP-SBJ *)
          (PP-PRD (IP-ADV (PP (NP (IP-REL (NP-SBJ *T*)
                                          (PP (NP (NUMCLP (NUM １)
                                                          (CL cm))
                                                  (N あたり))
                                              (P に))
                                          (ADJN 必要)
                                          (AX な))
                                  (N 細胞))
                              (P が))
                          (NP-SBJ *が*)
                          (ADVP (ADJN 数段)
                                (AX に))
                          (ADJI 多い))
                  (P から))
          (AX です))
  (ID 129_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (ADVP (ADV 例えば))
          (NP-PRD (N 耳))
          (AX です))
  (ID 130_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (N 軟骨細胞))
              (P を))
          (NP-OB1 *を*)
          (VB のせ)
          (P て)
          (VB2 いる)
          (FN ところ)
          (AX です))
  (ID 131_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP-TMP (NP (IP-EMB (NP-OB1 *pro*)
                              (PP (NP (N 細胞))
                                  (P で))
                              (VB 覆っ)
                              (AXD た))
                      (N 後))
                  (P は))
          (NP-OB1 *pro*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PP (NP (N オーブン))
                                      (P の))
                                  (N よう))
                          (AX な))
                  (N 装置))
              (P に))
          (VB 入れ)
          (AX ます))
  (ID 132_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そして)
          (NP-TMP (NUMCLP (NUM 数)
                          (CL 週間))
                  (N 後))
          (PP (NP (IP-EMB (PP (NP (PP (NP (N 軟骨))
                                      (P の))
                                  (N 骨組み))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 取り外す))
                  (N 事))
              (P が))
          (NP-OB1 *が*)
          (VB でき)
          (AX ます))
  (ID 133_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (N 指))
              (P を))
          (NP-OB1 *を*)
          (VB つくっ)
          (P て)
          (VB2 いる)
          (FN ところ)
          (AX です))
  (ID 134_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-ADV (NUMCLP (NUM 一)
                          (CL 層))
                  (NUMCLP (NUM 一)
                          (CL 層)))
          (VB 積み重ね)
          (PASS られ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 135_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (IP-ADV (PP (NP (N 最初))
                              (P に))
                          (PP (NP (CONJP (NP (N 骨))
                                         (CONJ そして))
                                  (NP (N 隙間)))
                              (P を))
                          (NP-OB1 *を*)
                          (PP (NP (N 軟骨))
                              (P で))
                          (VB ふさぎ))
                  (CONJ *)
                  (PP (NP (N 筋肉))
                      (P を))
                  (NP-OB1 *を*)
                  (PP (NP (N 上))
                      (P に))
                  (VB のせ)
                  (P て))
          (CONJ *)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 固形組織))
                          (AX の))
                  (N 層))
              (P を))
          (NP-OB1 *を*)
          (VB 積み重ね)
          (AX ます))
  (ID 136_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (IP-ADV (NP-SBJ *speaker*)
                      (NP-OB1 *pro*)
                      (VB 繰り返し)
                      (AX ます))
              (P が))
          (CONJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (ADVP (ADV かなり))
                          (ADJN 複雑)
                          (AX な))
                  (N 臓器))
          (AX です))
  (ID 137_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ しかし)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 他))
                              (P と)
                              (P は))
                          (PP (NP (N 比べ物))
                              (P に))
                          (VB なら)
                          (NEG ない))
                  (IP-REL (NP-SBJ *T*)
                          (ADJN 複雑)
                          (AX な))
                  (N 固形臓器))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 血管))
                              (P が))
                          (NP-SBJ2 *が*)
                          (ADJI 多い))
                  (N 臓器))
          (AX です))
  (ID 138_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 血管))
                              (P が))
                          (NP-SBJ2 *が*)
                          (ADJI 多い))
                  (N の))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (NP-PRD (CONJP (NP (N 心臓)))
                                  (CONJP (NP (N 肝臓))
                                         (CONJ そして))
                                  (NP (N 腎臓))
                                  (P など))
                          (AX の))
                  (N 臓器))
          (AX です))
  (ID 139_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (PP (NP (IP-EMB (NP-SBJ *speaker+pro*)
                                      (PP (NP (N 固形臓器))
                                          (P を))
                                      (NP-OB1 *を*)
                                      (VB つくる))
                              (N 方法))
                          (P は))
                      (NP-SBJ *)
                      (NP;*SBJ* (NUMCLP (WNUM いく)
                                        (CL つ))
                                (P か))
                      (VB あり)
                      (AX ます))
              (P が))
          (CONJ *)
          (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (D その)
                  (NUMCLP (NUM 一)
                          (CL 例)))
          (AX です))
  (ID 140_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO 私たち))
              (P は))
          (NP-SBJ *)
          (PP (NP (N プリンター))
              (P を))
          (NP-OB1 *を*)
          (VB 使い)
          (AX ます))
  (ID 141_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (N インク))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 使う)
                  (FN の)
                  (AX で)
                  (P は)
                  (NEG なく))
          (CONJ *)
          (PP (NP (N 細胞))
              (P を))
          (NP-OB1 *を*)
          (VB 使い)
          (AX ます))
  (ID 142_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 普通))
                          (AX の))
                  (N プリンター))
          (AX です))
  (ID 143_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (ADVP (ADV 実は))
          (PP (NP (PP (NP (N 心臓))
                      (P の))
                  (PP;* (NP (NUMCLP (NUM 二)
                                    (CL つ)))
                        (P の))
                  (N 小室))
              (P を))
          (NP-OB1 *を*)
          (PP;*OB1* (NP (NUMCLP (NUM 一)
                                (CL 層)))
                    (P ずつ))
          (VB プリント)
          (VB0 し)
          (P て)
          (VB2 いる)
          (FN の)
          (AX です))
  (ID 144_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (IP-ADV (PP (NP (IP-REL (NP-OB1 *T*)
                                  (NP-SBJ *hearer*)
                                  (VB ご覧)
                                  (P に)
                                  (VB2 なっ)
                                  (P て)
                                  (VB2 いる))
                          (N の))
                      (P は))
                  (NP-SBJ *)
                  (NP-PRD (N 心臓))
                  (AX で))
          (CONJ *)
          (IP-ADV (PP (NP (NUMCLP (NUM 約40)
                                  (CL 分)))
                      (P で))
                  (PP (NP (N 印刷))
                      (P が))
                  (NP-SBJ *が*)
                  (VB 終了)
                  (VB0 し))
          (PP (NP (NML (PP (NP (NUMCLP (NUM ４)
                                       (CL 時間)))
                           (P から))
                       (NUMCLP (NUM ６)
                               (CL 時間)))
                  (N 後))
              (P に)
              (P は))
          (PP (NP (N 筋肉))
              (P が))
          (NP-SBJ *が*)
          (VB 収縮)
          (VB0 し)
          (VB2 始め)
          (AX ます))
  (ID 145_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (NP-PRD (IP-REL (NP-OB1 *T*)
                          (PP (NP (IP-REL (NP-SBJ *T*)
                                          (PP (NP (PP (NP (PRO 私達))
                                                      (P の))
                                                  (N 研究所))
                                              (P に))
                                          (VB い)
                                          (AXD た))
                                  (NPR タオ・ジュ氏))
                              (P が))
                          (NP-SBJ *が*)
                          (VB 開発)
                          (VB0 し)
                          (AXD た))
                  (N 技術))
          (AX です))
  (ID 146_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (D この)
                  (N 技術))
              (P は))
          (NP-SBJ *)
          (IP-ADV (NP-PRD (IP-REL (NP-SBJ *T*)
                                  (ADJN 試験的)
                                  (AX な))
                          (N もの))
                  (AX で))
          (CONJ *)
          (ADVP (ADV まだ))
          (NP-PRD (IP-EMB (NP-SBJ *speaker+pro*)
                          (NP-OB1 *pro*)
                          (PP (NP (N 患者))
                              (P に))
                          (VB 使用)
                          (VB0 できる))
                  (N 段階))
          (AX で)
          (P は)
          (VB2 あり)
          (AX ませ)
          (NEG ん))
  (ID 147_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ また)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (VB 脱細胞化)
                          (VB0 し)
                          (AX た))
                  (N 臓器))
              (P も))
          (NP-OB1 *)
          (VB 使用)
          (VB0 し)
          (AX まし)
          (AXD た))
  (ID 148_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (IP-REL (NP-SBJ *T*)
                                  (VB ドナー提供)
                                  (VB0 さ)
                                  (PASS れ)
                                  (AXD た))
                          (N 臓器))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 用い)
                  (P て))
          (CONJ *)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 刺激))
                              (P の))
                          (NP-SBJ2 *の*)
                          (ADJI 少ない))
                  (N 洗浄剤))
              (P で))
          (PP (NP (PP;* (NP (Q すべて))
                        (P の))
                  (N 細胞成分))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PRO これら))
                          (AX の))
                  (N 臓器))
              (P から))
          (VB 取り出し)
          (AX ます))
  (ID 149_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (CONJP (NP (PP (NP (N 左手))
                                 (P の))
                             (N パネル))
                         (P と))
                  (NP (PP (NP (N 上))
                          (P の))
                      (N パネル)))
              (P は))
          (NP-SBJ *)
          (NP-PRD (N 肝臓))
          (AX です))
  (ID 150_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (VB ドナー提供)
                          (VB0 さ)
                          (PASS れ)
                          (AXD た))
                  (N 肝臓))
              (P を))
          (NP-OB1 *を*)
          (VB 洗浄)
          (VB0 し)
          (AX ます))
  (ID 151_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 刺激))
                              (P の))
                          (NP-SBJ2 *の*)
                          (ADJI 少ない))
                  (N 洗浄剤))
              (P で))
          (PP (NP (PP;* (NP (Q すべて))
                        (P の))
                  (N 細胞))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (N 肝臓))
              (P から))
          (VB 取り出す)
          (FN の)
          (AX です))
  (ID 152_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (NUMCLP (NUM ２)
                          (CL 週間))
                  (N 後))
              (P に)
              (P は))
          (PP (NP (IP-EMB (PP (NP (D この)
                                  (N 臓器))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 持ち上げる))
                  (N 事))
              (P が))
          (NP-OB1 *が*)
          (VB でき)
          (AX ます))
  (ID 153_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ (CONJP (NP (N 見た目))
                                     (P も))
                              (NP (N 感触))
                              (P も))
                      (NP-PRD (PP (NP (IP-REL (NP-SBJ *T*)
                                              (NP-PRD (N 本物))
                                              (AX の))
                                      (N 肝臓))
                                  (P の))
                              (N よう))
                      (AX です))
              (P が))
          (CONJ *)
          (PP (NP (N 細胞))
              (P は))
          (NP-SBJ *)
          (VB あり)
          (AX ませ)
          (NEG ん))
  (ID 154_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ *speaker+pro*)
                      (PP (NP (N 肝臓))
                          (P を))
                      (NP-OB1 *を*)
                      (VB 取り除く))
              (P と))
          (CND *)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N コラーゲン製))
                          (AX の))
                  (N 骨組み))
              (P が))
          (NP-SBJ *が*)
          (VB 残り)
          (AX ます))
  (ID 155_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N コラーゲン))
              (P は))
          (NP-SBJ *)
          (PP (NP (IP-EMB (PP (NP (N 拒絶反応))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 起こす))
                  (N こと))
              (P が))
          (NP-OB1 *が*)
          (VB あり)
          (AX ませ)
          (NEG ん))
  (ID 156_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (PRO これ))
              (P は))
          (NP-OB1 *)
          (PP (NP (PP;* (NP (NUMCLP (WNUM 何)
                                    (CL 人)))
                        (P も)
                        (P の))
                  (N 患者))
              (P に))
          (VB 使用)
          (VB0 でき)
          (AX ます))
  (ID 157_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そして)
          (IP-ADV (PP (NP (D この)
                          (N 血管組織))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 取り出し))
          (PP (NP (PP (NP (PP (NP (N 血管))
                              (P の))
                          (N 供給))
                      (P の))
                  (N 維持))
              (P を))
          (NP-OB1 *を*)
          (VB 証明)
          (VB0 でき)
          (AX ます))
  (ID 158_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (N フローラスコピー))
          (AX です))
  (ID 159_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *hearer*)
                          (VB ご覧)
                          (P に)
                          (VB2 なっ)
                          (P て)
                          (VB2 いる))
                  (N の))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-EMB (NP-SBJ *speaker+pro*)
                          (PP (NP (N 造影剤))
                              (P を))
                          (NP-OB1 *を*)
                          (PP (NP (IP-REL (NP-SBJ *T*)
                                          (VB 脱細胞化)
                                          (VB0 し)
                                          (AX た))
                                  (N 肝臓))
                              (P に))
                          (VB 注入)
                          (VB0 し)
                          (P て)
                          (VB2 いる))
                  (N ところ))
          (AX です))
  (ID 160_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (PP (NP (N 無傷))
                                      (P の))
                                  (N まま))
                          (AX の))
                  (N 血管樹))
              (P が))
          (NP-SBJ *が*)
          (VB 見え)
          (AX ます))
  (ID 161_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そこで)
          (PP-1 (NP (IP-REL (NP-SBJ *T*)
                            (PP (NP (PP (NP (N 木))
                                        (P の))
                                    (N よう))
                                (P に))
                            (VB 枝分かれ)
                            (VB0 し)
                            (AXD た))
                    (N 血管))
                (P に))
          (PP (NP (PP (NP (N 患者)
                          (PRN (NP (PRO 自身))))
                      (P の))
                  (N 細胞))
              (P を))
          (NP-OB1 *を*)
          (IP-SMC (PP *ICH*-1)
                  (VB 行き渡ら))
          (VB せ)
          (AX ます))
  (ID 162_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (PP (NP (N 肝臓))
                      (P の))
                  (N 外側))
              (P に))
          (PP (NP (PP (NP (PP (NP (N 患者)
                                  (PRN (NP (PRO 自身))))
                              (P の))
                          (N 肝臓))
                      (P の))
                  (N 細胞))
              (P を))
          (NP-OB1 *を*)
          (PP (NP (N 一面))
              (P に))
          (VB 散布)
          (VB0 し)
          (AX ます))
  (ID 163_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (IP-EMB (PP (NP (N 肝臓))
                              (P を))
                          (NP-OB1 *を*)
                          (IP-SMC (VB 機能)
                                  (VB0 さ))
                          (VB せる))
                  (N よう))
              (P に))
          (VB し)
          (AX ます))
  (ID 164_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *hearer*)
                          (VB ご覧)
                          (P に)
                          (VB2 なっ)
                          (P て)
                          (VB2 いる))
                  (N の))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (PRO それ))
          (AX です))
  (ID 165_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (IP-ADV (NP-SBJ *pro*)
                      (ADVP (ADV まだ))
                      (NP-PRD (N 試験段階))
                      (AX です))
              (P が))
          (CONJ *)
          (PP (NP (PP (NP (N 肝臓機能))
                      (P の))
                  (N 再生))
              (P を))
          (NP-OB1 *を*)
          (IP-SMC (VB 成功)
                  (VB0 さ))
          (VB せ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 166_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (PP (NP (N 腎臓))
              (P に))
          (PP (NP (N 話))
              (P を))
          (NP-OB1 *を*)
          (VB 移し)
          (AX ます))
  (ID 167_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ *pro*)
                      (PP (NP (IP-REL (NP-OB1 *T*)
                                      (NP-SBJ *speaker*)
                                      (PP (NP (PP (NP (N 講演))
                                                  (P の))
                                              (N 最初))
                                          (P に))
                                      (VB お見せ)
                                      (VB0 し)
                                      (AXD た))
                              (N 絵))
                          (P で)
                          (P も))
                      (PP (NP (N 腎臓移植))
                          (P を))
                      (NP-OB1 *を*)
                      (VB し)
                      (P て)
                      (VB2 い)
                      (AX まし)
                      (AXD た))
              (P が))
          (CONJ *)
          (PP (NP (PP (NP (IP-REL (NP-SBJ *T*)
                                  (PP (NP (N 臓器移植))
                                      (P が))
                                  (NP-SBJ2 *が*)
                                  (ADJN 必要)
                                  (AX な))
                          (N 患者))
                      (P の))
                  (NUMCLP (NUM 90)
                          (CL %)))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 腎臓移植))
                              (P が))
                          (NP-SBJ2 *が*)
                          (ADJN 必要)
                          (AX な))
                  (N 方たち))
          (AX です))
  (ID 168_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-OB1 *T*)
                          (PP (NP (PRO 私たち))
                              (P が))
                          (NP-SBJ *が*)
                          (VB 試み)
                          (P て)
                          (VB2 いる))
                  (PP;* (NP (ADV もう)
                            (NUMCLP (NUM 一)
                                    (CL つ)))
                        (P の))
                  (N 方法))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-EMB (NP-SBJ *speaker+pro*)
                          (IP-ADV (PP (NP (N ウェハー))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB つくり))
                          (PP (NP (PRO それ))
                              (P を))
                          (NP-OB1 *を*)
                          (PP (NP (PP (NP (N アコーディオン))
                                      (P の))
                                  (N よう))
                              (P に))
                          (VB 積み重ねる))
                  (N 方法))
          (AX です))
  (ID 169_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (PP (NP (N 腎臓))
                              (P の))
                          (N 細胞))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 使っ)
                  (P て))
          (CONJ *)
          (PP (NP (N ウェハー))
              (P を))
          (NP-OB1 *を*)
          (VB 重ね)
          (AX ます))
  (ID 170_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-OB1 *T*)
                          (PP (NP (PRO 私たち))
                              (P が))
                          (NP-SBJ *が*)
                          (VB つくっ)
                          (AXD た))
                  (PNL 小さな)
                  (N 腎臓))
          (AX です))
  (ID 171_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これら))
              (P は))
          (NP-SBJ *)
          (ADVP (ADV 実は))
          (PP (NP (N 尿))
              (P を))
          (NP-OB1 *を*)
          (VB つくり出し)
          (P て)
          (VB2 いる)
          (FN の)
          (AX です))
  (ID 172_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (CP-THT (CP-QUE (IP-SUB (NP-SBJ *speaker+pro*)
                                          (PP (NP (PNL 小さな)
                                                  (N 組織))
                                              (P を))
                                          (NP-OB1 *を*)
                                          (ADVP (WADV どうやって))
                                          (ADJI 大きく)
                                          (VB2 する))
                                  (P か))
                          (P という))
                  (N 難題))
              (P に))
          (NP-TMP (N 今))
          (PP (NP (PP (NP (PRO 私達))
                      (P の))
                  (N 研究所))
              (P で))
          (VB 取り組ん)
          (P で)
          (VB2 い)
          (AX ます))
  (ID 173_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (IP-REL (NP-OB1 *T*)
                                  (NP-SBJ *speaker*)
                                  (PP (NP (Q 皆さん))
                                      (P に))
                                  (VB お話し)
                                  (VB0 し)
                                  (AX たかっ)
                                  (AXD た))
                          (N 事))
                      (P の))
                  (NUMCLP (NUM ひと)
                          (CL つ)))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-OB1 *T*)
                          (PP (NP (N 再生医療))
                              (P が))
                          (NP-SBJ *が*)
                          (VB 取ろ)
                          (MD うとし)
                          (P て)
                          (VB2 いる))
                  (N 戦略))
          (AX です))
  (ID 174_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CP-THT (IP-SUB (NP-SBJ *speaker+pro*)
                          (PP (IP-ADV (NP-SBJ *speaker+pro*)
                                      (ADVP (ADV もし))
                                      (ADJN 可能)
                                      (AX *))
                              (P ならば))
                          (CND *)
                          (IP-ADV (PP (NP (IP-REL (NP-SBJ *T*)
                                                  (NP-PRD (N 既製))
                                                  (AX の))
                                          (IP-REL (NP-SBJ *T*)
                                                  (ADJN 高性能)
                                                  (AX な))
                                          (N 生体材料))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB 使っ)
                                  (P て))
                          (CONJ *)
                          (PP (NP (PP (NP (N 患者))
                                      (P の))
                                  (N 臓器))
                              (P を))
                          (NP-OB1 *を*)
                          (IP-SMC (VB 再生)
                                  (VB0 さ))
                          (VB せ)
                          (AX たい))
                  (P と))
          (VB 思っ)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 175_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (PP (NP (IP-EMB (NP-SBJ *speaker+pro*)
                                      (NP-OB1 *pro*)
                                      (VB 再生)
                                      (VB0 できる))
                              (N 幅))
                          (P は))
                      (NP-SBJ *)
                      (VB 限ら)
                      (PASS れ)
                      (P て)
                      (VB2 い)
                      (AX ます))
              (P が))
          (CONJ *)
          (PP (NP (N 目標))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-EMB (NP-SBJ *speaker+pro*)
                          (PP (NP (D その)
                                  (N 大きさ))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 広げ)
                          (P て)
                          (VB2 いく))
                  (N こと))
          (AX です))
  (ID 176_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (IP-ADV (PP (NP (PP (NP (IP-REL (NP-SBJ *T*)
                                              (ADJN 高性能)
                                              (AX な))
                                      (N 生体材料))
                                  (P の))
                              (N 使用))
                          (P が))
                      (NP-SBJ *が*)
                      (ADJN だめ)
                      (AX *))
              (P なら))
          (CND *)
          (NP-PRD (IP-EMB (NP-SBJ *speaker+pro*)
                          (PP (NP (PP (NP (PRO 自分))
                                      (P の))
                                  (N 細胞))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 使う))
                  (N こと))
          (AX です))
  (ID 177_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP-PRD (IP-ADV (NP-SBJ *pro*)
                          (PP (NP (N 拒絶反応))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 起こさ)
                          (NEG ない))
                  (P から))
          (AX です))
  (ID 178_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (IP-ADV (PP (NP (Q 皆さん))
                      (P から))
                  (PP (NP (N 細胞))
                      (P を))
                  (NP-OB1 *を*)
                  (VB 取り出し))
          (PP (NP (N 組織))
              (P を))
          (NP-OB1 *を*)
          (VB つくり出す))
  (ID 179_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ そして)
          (PP (NP (PRO それ))
              (P を))
          (NP-OB1 *を*)
          (NP-ADV (D その)
                  (N まま))
          (PP (NP (Q 皆さん))
              (P に))
          (VB 返す))
  (ID 180_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (IP-ADV (NP-SBJ *speaker+pro*)
                  (ADVP (ADV そう))
                  (VB すれ)
                  (P ば))
          (CND *)
          (PP (NP (N 拒絶反応))
              (P は))
          (NP-SBJ *)
          (VB 起き)
          (AX ませ)
          (NEG ん))
  (ID 181_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ *pro*)
                      (ADVP (ADV もし))
                      (ADJN 可能)
                      (AX *))
              (P なら))
          (CND *)
          (PP (NP (PP (NP (IP-REL (NP-SBJ *T*)
                                  (NP-PRD (N 特定))
                                  (AX の))
                          (N 臓器))
                      (P の))
                  (N 細胞))
              (P が))
          (NP-SBJ *が*)
          (ADJI 好ましい)
          (FN の)
          (AX です))
  (ID 182_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP-ADV (NP (IP-EMB (PP (NP (N 気管))
                                  (P に))
                              (PP (NP (N 問題))
                                  (P が))
                              (NP-SBJ *が*)
                              (VB ある))
                      (N 場合))
                  (P は))
          (PP (NP (PP (NP (N 気管))
                      (P の))
                  (N 細胞))
              (P を))
          (NP-OB1 *を*)
          (VB 取り出し)
          (AX ます))
  (ID 183_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (NP-PRD (IP-EMB (PP-ADV (NP (IP-EMB (PP (NP (N 膵臓))
                                                  (P に))
                                              (PP (NP (N 問題))
                                                  (P が))
                                              (NP-SBJ *が*)
                                              (VB ある))
                                      (N 場合))
                                  (P は))
                          (PP (NP (PP (NP (N 膵臓))
                                      (P の))
                                  (N 細胞))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 取り出す))
                  (N わけ))
          (AX です))
  (ID 184_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (N 理由))
              (P は))
          (NP-SBJ *)
          (PP-PRD (IP-ADV (PP (NP (IP-REL (NP-OB1 *T*)
                                          (NP-SBJ *speaker+pro*)
                                          (VB 採取)
                                          (VB0 する))
                                  (N 細胞))
                              (P は))
                          (NP-SBJ *)
                          (CP-QUE (IP-SUB (PP (NP (PRO 自ら))
                                              (P が))
                                          (NP-SBJ *が*)
                                          (NP-PRD (PP (NP (WPRO 何))
                                                      (P の))
                                                  (N 細胞))
                                          (AX な)
                                          (FN の))
                                  (P か))
                          (VB わかっ)
                          (P て)
                          (VB2 いる))
                  (P から))
          (AX です))
  (ID 185_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (PP (NP (PP (NP (N 気管))
                                  (P の))
                              (N 細胞))
                          (P は))
                      (NP-SBJ *)
                      (CP-THT (IP-SUB (PP (NP (PRO 自身))
                                          (P が))
                                      (NP-SBJ *が*)
                                      (NP-PRD (PP (NP (N 気管))
                                                  (P の))
                                              (N 細胞))
                                      (AX だ))
                              (P と))
                      (VB わかっ)
                      (P て)
                      (VB2 いる))
              (P ので))
          (SCON *)
          (PP (NP (IP-EMB (NP-SBJ *speaker+pro*)
                          (NP-OB2 *pro*)
                          (CP-QUE (IP-SUB (NP-SBJ *pro*)
                                          (PP (NP (WD どんな)
                                                  (N 細胞))
                                              (P に))
                                          (NP-OB1 *に*)
                                          (VB なる)
                                          (FN の))
                                  (P か))
                          (VB 教える))
                  (N 必要))
              (P が))
          (NP-SBJ *が*)
          (VB あり)
          (AX ませ)
          (NEG ん))
  (ID 186_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ よって)
          (PP (NP (PP (NP (IP-REL (NP-SBJ *T*)
                                  (NP-PRD (N 特定))
                                  (AX の))
                          (N 臓器))
                      (P の))
                  (N 細胞))
              (P が))
          (NP-SBJ *が*)
          (ADJI いい)
          (FN の)
          (AX です))
  (ID 187_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (NP-SBJ *speaker+pro*)
                      (PP (NP (N 今))
                          (P で)
                          (P は))
                      (PP (NP (IP-EMB (PP (NP (PP;* (NP (Q 大半))
                                                    (P の))
                                              (N 臓器))
                                          (P から))
                                      (PP (NP (N 細胞))
                                          (P を))
                                      (NP-OB1 *を*)
                                      (VB 得る))
                              (N こと))
                          (P が))
                      (NP-OB1 *が*)
                      (VB でき)
                      (AX ます))
              (P が))
          (CONJ *)
          (IP-ADV (PP (NP (CONJP (NP (N 心臓)))
                          (CONJP (NP (N 肝臓)))
                          (CONJP (NP (N 神経)))
                          (NP (N 膵臓))
                          (P など))
                      (P が))
                  (NP-SBJ *が*)
                  (NP-PRD (D その)
                          (N 例外))
                  (AX で))
          (CONJ *)
          (PP (NP (PRO それら))
              (P に)
              (P は))
          (PP (ADVP (ADV 依然))
              (P として))
          (PP (NP (N 幹細胞))
              (P が))
          (NP-OB1 *が*)
          (ADJN 必要)
          (AX です))
  (ID 188_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP-ADV (NP (IP-EMB (ADVP (ADV もし))
                              (PP (NP (PP (NP (N 患者)
                                              (PRN (NP (PRO 自身))))
                                          (P の))
                                      (N 幹細胞))
                                  (P を))
                              (NP-OB1 *を*)
                              (VB 使え)
                              (NEG ない))
                      (N 場合))
                  (P は))
          (PP (NP (PP (NP (N ドナー))
                      (P の))
                  (N 幹細胞))
              (P を))
          (NP-OB1 *を*)
          (VB 使い)
          (AX ます))
  (ID 189_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (IP-ADV (PP (NP (N 拒絶反応))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB 起こさ)
                                  (NEG ず))
                          (CONJ *)
                          (PP (NP (N 腫瘍))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 形成)
                          (VB0 し)
                          (NEG ない))
                  (N 細胞))
              (P を))
          (NP-OB1 *を*)
          (VB 選び)
          (AX ます))
  (ID 190_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (IP-REL (NP-SBJ *T*)
                                          (NP-PRD (D その)
                                                  (N よう))
                                          (AX な))
                                  (N 特性))
                              (P を))
                          (NP-OB1 *を*)
                          (VB もっ)
                          (P て)
                          (VB2 いる))
                  (N の))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *speaker+pro*)
                          (PP (NP (NUMCLP (NUM ２)
                                          (CL 年))
                                  (N 前))
                              (P に))
                          (VB 発表)
                          (VB0 し)
                          (AXD た))
                  (N 幹細胞))
          (AX です))
  (ID 191_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (IP-ADV (PP (NP (D その)
                          (N 幹細胞))
                      (P と)
                      (P は))
                  (NP-OB1 *と*)
                  (PP (NP (CONJP (NP (N 羊水))
                                 (P や))
                          (NP (N 胎盤)))
                      (P から))
                  (VB 採取)
                  (VB0 でき))
          (PP (NP (PRO 私たち))
              (P は))
          (NP-SBJ *)
          (PP (NP (D その)
                  (N 研究))
              (P に))
          (VB 取り組ん)
          (P で)
          (VB2 い)
          (AX ます))
  (ID 192_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (CP-THT (IP-SUB (NP-SBJ *speaker*)
                          (PP (NP (PP;* (NP (NUMCLP (WNUM いく)
                                                    (CL つ)))
                                        (P か)
                                        (P の))
                                  (N 難題))
                              (P について))
                          (NP-OB1 *について*)
                          (VB お話し)
                          (AX たい))
                  (P と))
          (VB 思い)
          (AX ます))
  (ID 193_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (IP-ADV (PP (NP (IP-REL (NP-OB1 *T*)
                                      (NP-SBJ *speaker*)
                                      (VB 紹介)
                                      (VB0 し)
                                      (AXD た))
                              (N 技術))
                          (P は))
                      (NP-SBJ *)
                      (ADVP (ADJN 順調)
                            (AX に))
                      (VB 見え)
                      (AX ます))
              (P が))
          (CONJ *)
          (PP (NP (PP (NP (N 現実))
                      (P の))
                  (N 答え))
              (P は))
          (NP-SBJ *)
          (NP-PRD (N ノー))
          (AX な)
          (FN の)
          (AX です))
  (ID 194_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (NP (PRO それ))
              (P ほど))
          (ADJN 簡単)
          (AX で)
          (P は)
          (VB2 あり)
          (AX ませ)
          (NEG ん))
  (ID 195_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (IP-REL (NP-OB1 *T*)
                                  (NP-SBJ *speaker*)
                                  (NP-TMP (N 今日))
                                  (VB 紹介)
                                  (VB0 し)
                                  (AXD た))
                          (N 内容))
                      (P の))
                  (Q 一部))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-OB1 *T*)
                          (PP (NP (PP (NP (PRO 我々))
                                      (P の))
                                  (N 研究所))
                              (P で))
                          (PP (NP (PP;* (NP (NUMCLP (NUM 700)
                                                    (CL 人))
                                            (N 以上))
                                        (P の))
                                  (N 研究者))
                              (P が))
                          (NP-SBJ *が*)
                          (IP-ADV (PP (NP (PP;* (NP (NUMCLP (NUM 20)
                                                            (CL 年)))
                                                (P の))
                                          (N 年月))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB 経)
                                  (P て))
                          (CONJ *)
                          (VB 成し遂げ)
                          (AXD た))
                  (N もの))
          (AX です))
  (ID 196_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (IP-ADV (NP-SBJ *pro*)
                  (NP-PRD (IP-REL (NP-SBJ *T*)
                                  (ADVP (ADV とても))
                                  (ADJI 難しい))
                          (N 技術))
                  (AX で)
                  (VB2 あっ)
                  (P て))
          (CONJ *)
          (PP (IP-ADV (NP-SBJ *speaker+pro*)
                      (PP (NP (IP-REL (NP-SBJ *T*)
                                      (ADJI 正しい))
                              (N 方式))
                          (P を))
                      (NP-OB1 *を*)
                      (VB 見出す))
              (P まで))
          (SCON *)
          (PP (NP (N 道のり))
              (P は))
          (NP-SBJ *)
          (ADJI 長い)
          (FN の)
          (AX です))
  (ID 197_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-IMP (NP-SBJ *hearer*)
          (ADVP (ADV ぜひ))
          (PP (NP (D この)
                  (N 漫画))
              (P を))
          (NP-OB1 *を*)
          (VB 見)
          (P て)
          (VB2 ください))
  (ID 198_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (NP-PRD (PP (NP (PP (NP (IP-REL (NP-SBJ *T*)
                                          (VB 暴走)
                                          (VB0 し)
                                          (AXD た))
                                  (N 馬車))
                              (P の))
                          (N 阻止))
                      (P の))
                  (N 仕方))
          (AX です))
  (ID 199_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (N 馬車))
                      (P の))
                  (N 御者))
              (P が))
          (NP-SBJ *が*)
          (PP (NP (PP (NP (N 上))
                      (P の))
                  (N 絵))
              (P で)
              (P は))
          (IP-ADV (IP-ADV (PP (NP (PP (NP (N 馬))
                                      (P の))
                                  (N 背))
                              (P を))
                          (NP-OB1 *を*)
                          (VB たどっ)
                          (P て))
                  (CONJ *)
                  (PP (NP (IP-REL (NP-SBJ *T*)
                                  (NP-PRD (N 先頭))
                                  (AX の))
                          (N 馬))
                      (P まで))
                  (VB 進ん)
                  (P で)
                  (VB2 いき))
          (CONJ *)
          (PP (NP (N 最後))
              (P に))
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (VB 暴走)
                          (VB0 し)
                          (AXD た))
                  (N 馬車))
              (P を))
          (NP-OB1 *を*)
          (VB 阻止)
          (VB0 し)
          (AX ます))
  (ID 200_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (NP (N 科学者))
              (P なら))
          (ADVP (ADV そう))
          (VB する)
          (MD でしょう))
  (ID 201_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-SBJ *T*)
                          (PP (NP (N 下))
                              (P に))
                          (VB いる))
                  (N の))
              (P は))
          (NP-SBJ *)
          (NP-ADV (N 通常))
          (NP-PRD (N 外科医))
          (AX です))
  (ID 202_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (PP (NP (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 外科医))
                          (AX の))
                  (PRO 私))
              (P に)
              (P は))
          (ADJI 面白く)
          (VB2 あり)
          (AX ませ)
          (NEG ん))
  (ID 203_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ しかし)
          (ADVP (ADV 実は))
          (PP (NP (PP (NP (N 上))
                      (P の))
                  (N 方法))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (ADJI 正しい))
                  (N 取り組み方))
          (AX な)
          (FN の)
          (AX です))
  (ID 204_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP-TPC (NP (IP-REL (NP-OB1 *T*)
                              (PP (NP (PRO それ))
                                  (P が))
                              (NP-SBJ *が*)
                              (VB 意味)
                              (VB0 する))
                      (N の))
                  (P は))
          (PP-TMP (NP (IP-EMB (PP (NP (IP-REL (NP-SBJ *T*)
                                              (NP-PRD (D この)
                                                      (N よう))
                                              (AX な))
                                      (N 技術))
                                  (P を))
                              (NP-OB1 *を*)
                              (PP (NP (N 病院))
                                  (P で))
                              (PP (NP (N 患者))
                                  (P に))
                              (VB 着手)
                              (VB0 する))
                      (N 時))
                  (P は))
          (PP (NP (WD どんな)
                  (N 時))
              (P でも))
          (PP (NP (N 絶対))
              (P に))
          (NP-ADV (IP-EMB (NP-OB1 *pro*)
                          (PP (IP-ADV (NP-SBJ *speaker+pro*)
                                      (PP (NP (PP (NP (IP-REL (NP-OB1 *T*)
                                                              (NP-SBJ *speaker+pro*)
                                                              (PP (NP (N 研究室))
                                                                  (P で))
                                                              (VB やれる))
                                                      (N 事))
                                                  (P の))
                                              (Q すべて))
                                          (P を))
                                      (NP-OB1 *を*)
                                      (VB やっ)
                                      (P て))
                              (P から)
                              (P に))
                          (NP-OB2 *から*)
                          (VB する))
                  (N よう))
          (VB 徹底)
          (VB0 し)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 205_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (CONJ また)
          (PP (NP (IP-EMB (PP (NP (IP-EMB (PP (NP (IP-REL (NP-SBJ *T*)
                                                          (NP-PRD (PRO これら))
                                                          (AX の))
                                                  (N 技術))
                                              (P を))
                                          (NP-OB1 *を*)
                                          (PP (NP (N 患者))
                                              (P に))
                                          (VB 施す))
                                  (N 前))
                              (P に))
                          (PP (NP (PRO 自ら))
                              (P に))
                          (PP (NP (IP-REL (NP-SBJ *T*)
                                          (ADVP (ADV とても))
                                          (ADJI 難しい))
                                  (N 問いかけ))
                              (P を))
                          (NP-OB1 *を*)
                          (VB する))
                  (N よう))
              (P に))
          (NP-OB1 *pro*)
          (VB 徹底)
          (VB0 し)
          (P て)
          (VB2 い)
          (AX ます))
  (ID 206_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (IP-ADV (IP-ADV (NP-SBJ *speaker+pro*)
                              (PP (CP-QUE (IP-SUB (NP-SBJ *speaker+pro*)
                                                  (PP (IP-ADV (PP (NP (PP (NP (PRO 自分))
                                                                          (P の))
                                                                      (IP-REL (NP-SBJ *T*)
                                                                              (ADJN 大切)
                                                                              (AX な))
                                                                      (N 人))
                                                                  (P に))
                                                              (PP (NP (D この)
                                                                      (N 臓器移植))
                                                                  (P を))
                                                              (NP-OB1 *を*)
                                                              (VB し)
                                                              (P て))
                                                      (P も))
                                                  (CND *)
                                                  (VB 差し支え)
                                                  (NEG ない))
                                          (P か))
                                  (P を))
                              (NP-OB1 *を*)
                              (VB 問い))
                      (CONJ *)
                      (PP (NP (D その)
                              (N 答え))
                          (P が))
                      (NP-SBJ *が*)
                      (NP-PRD (N イエス))
                      (AX *))
              (P なら))
          (CND *)
          (PP (NP (N 事))
              (P を))
          (NP-OB1 *を*)
          (VB 進め)
          (AX ます))
  (ID 207_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *pro*)
          (CONJ なぜなら)
          (PP-PRD (IP-ADV (PP (NP (IP-REL (NP-SBJ *T*)
                                          (NP-PRD (NUMCLP (NUM 第一)))
                                          (AX の))
                                  (N 目標))
                              (P は))
                          (NP-SBJ *)
                          (NP-PRD (IP-EMB (NP-SBJ *pro*)
                                          (PP (NP (N 危害))
                                              (P を))
                                          (NP-OB1 *を*)
                                          (VB 与え)
                                          (NEG ない))
                                  (N こと))
                          (AX だ))
                  (P から))
          (AX です))
  (ID 208_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (CONJ では)
          (PP (IP-ADV (NP-SBJ *pro*)
                      (ADVP (ADV とても))
                      (ADJI 短い)
                      (FN の)
                      (AX です))
              (P が))
          (CONJ *)
          (PP (NP (PP (NP (IP-REL (NP-SBJ *T*)
                                  (PP (NP (PP (NP (IP-REL (NP-OB1 *T*)
                                                          (NP-SBJ *speaker+pro*)
                                                          (VB 培養)
                                                          (VB0 し)
                                                          (AXD た))
                                                  (N 臓器))
                                              (P の))
                                          (N 移植))
                                      (P を))
                                  (NP-OB1 *を*)
                                  (VB 受け)
                                  (AXD た))
                          (N 患者))
                      (P の))
                  (N ビデオ))
              (P を))
          (NP-OB1 *を*)
          (VB お見せ)
          (VB0 し)
          (AX ます))
  (ID 209_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (NP (PP (NP (IP-REL (NP-SBJ *T*)
                                  (NP-PRD (D この)
                                          (N よう))
                                  (AX な))
                          (N 組織))
                      (P の))
                  (N 移植))
              (P は))
          (NP-OB1 *)
          (PP (NP (NUMCLP (NUM 14)
                          (CL 年))
                  (N 以上)
                  (N 前))
              (P に))
          (VB 始め)
          (AX まし)
          (AXD た))
  (ID 210_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (CONJ ですから)
          (NP-PRD (CP-THT (IP-SUB (PP (NP (IP-REL (NP-SBJ *T*)
                                                  (IP-ADV (PP (NP (IP-REL (NP-SBJ *T*)
                                                                          (NP-PRD (D この)
                                                                                  (N よう))
                                                                          (AX な))
                                                                  (N 人工臓器))
                                                              (P を))
                                                          (NP-OB1 *を*)
                                                          (VB 抱え)
                                                          (P て))
                                                  (CONJ *)
                                                  (NP-TMP (NUMCLP (NUM 10)
                                                                  (CL 年))
                                                          (N 以上))
                                                  (ADVP (ADJN 元気)
                                                        (AX に))
                                                  (VB 歩き)
                                                  (VB2 まわっ)
                                                  (P て)
                                                  (VB2 いる))
                                          (N 患者))
                                      (P が))
                                  (NP-SBJ *が*)
                                  (VB いる))
                          (P という))
                  (N わけ))
          (AX です))
  (ID 211_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *speaker*)
                          (PP (NP (PRO これ))
                              (P から))
                          (VB お見せ)
                          (VB0 する))
                  (IP-REL (NP-SBJ *T*)
                          (ADJI 若い))
                  (N 女性患者))
              (P は))
          (NP-SBJ *)
          (PP (NP (IP-REL (PP (NP (N 脊髄異常))
                              (P が))
                          (NP-SBJ *が*)
                          (NP-PRD (PP (NP *T*)
                                      (P *の*))
                                  (N 原因))
                          (AX の))
                  (N 二分脊髄症))
              (P で))
          (VB 苦しん)
          (P で)
          (VB2 い)
          (AX まし)
          (AXD た))
  (ID 212_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PP (NP (PRO 彼女))
                      (P の))
                  (N 膀胱))
              (P は))
          (NP-SBJ *)
          (ADJN 正常)
          (AX で)
          (P は)
          (NEG なかっ)
          (AXD た))
  (ID 213_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (PP-PRD (NP (NPR CNNニュース))
                                  (P から))
                          (AX の))
                  (NUMCLP (NUM ひと)
                          (CL コマ)))
          (AX です))
  (ID 214_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (PP-TMP (NP (NUMCLP (NUM ５)
                              (CL 秒間)))
                  (P だけ))
          (NP-OB1 (N お時間))
          (VB 頂き)
          (AX ます))
  (ID 215_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO これ))
              (P は))
          (NP-SBJ *)
          (NP-PRD (IP-REL (PP (NP *T*)
                              (P *に*))
                          (PP (NP (NPR サンジェイ・グプタ))
                              (P が))
                          (NP-SBJ *が*)
                          (PP (NP (N 実際))
                              (P に))
                          (VB 携わっ)
                          (AXD た))
                  (NUMCLP (NUM ひと)
                          (CL コマ)))
          (AX です))
  (ID 216_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (ADJN 幸せ)
          (AX です))
  (ID 217_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (PP (NP (PRO 私))
              (P は))
          (NP-SBJ *)
          (ADVP (ADV いつも))
          (PP (NP (IP-EMB (PP (NP (PP (NP (N 事故))
                                      (P か))
                                  (WPRO 何)
                                  (P か))
                              (P で))
                          (PP (ADVP (WADV どう))
                              (P か))
                          (VB なる))
                  (N こと))
              (P を))
          (NP-OB1 *を*)
          (VB 恐れ)
          (P て)
          (VB2 い)
          (AX まし)
          (AXD た))
  (ID 218_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker*)
          (CONJ でも)
          (PP-TMP (NP (N 今))
                  (P は))
          (IP-ADV (PP (NP (N 友達))
                      (P と))
                  (PP (NP (N 外))
                      (P へ))
                  (VB 繰り出し))
          (PP (NP (IP-REL (NP-OB1 *T*)
                          (NP-SBJ *speaker*)
                          (VB やり)
                          (AX たい))
                  (N 事))
              (P が))
          (NP-OB1 *が*)
          (VB できる)
          (FN の)
          (AX です))
  (ID 219_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-ADV (PP (NP (N 結局))
                      (P の))
                  (N ところ))
          (PP (NP (PP (NP (N 再生医療))
                      (P の))
                  (N 将来性))
              (P が))
          (NP-SBJ *が*)
          (NP-PRD (IP-REL (NP-SBJ *T*)
                          (NP-PRD (N 唯一))
                          (AX の))
                  (N 希望))
          (AX な)
          (FN の)
          (AX です))
  (ID 220_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-SBJ *speaker+pro*)
          (PP (IP-ADV (NP-SBJ *pro*)
                      (PP (NP (N 本当))
                          (P に))
                      (ADVP (ADV とても))
                      (ADJN 簡単)
                      (AX です))
              (P が))
          (CONJ *)
          (PP (NP (PRO それ))
              (P だけ)
              (P で))
          (PP (NP (IP-EMB (PP (NP (N 患者))
                              (P に))
                          (NP-OB2 *に*)
                          (PP (NP (N 勇気))
                              (P を))
                          (NP-OB1 *を*)
                          (VB 与える))
                  (N 事))
              (P が))
          (NP-OB1 *が*)
          (VB できる)
          (FN の)
          (AX です))
  (ID 221_ted_talk_9;AnthonyAtala_2009P;JP))

( (IP-MAT (NP-OB1 (N ご清聴))
          (ADJI ありがとう)
          (VB ござい)
          (AX まし)
          (AXD た))
  (ID 222_ted_talk_9;AnthonyAtala_2009P;JP))
